Thursday, August 28, 2014 4:15:19 PM
4:07 PM ET 8/28/14 | Briefing.com
Reports Q2 (Jul) earnings of $0.01 per share, $0.03 better than the Capital IQ Consensus Estimate of ($0.02); revenues rose 51.7% year/year to $101.5 mln vs the $93.82 mln consensus.
Co issues upside guidance for Q3, sees Q3 revs of $105-107 mln vs. $104.37 mln Capital IQ Consensus Estimate; Operating margin expected to be 1%.Co issues upside guidance for FY15, sees FY15 revs of $423-428 mln vs. $411.60 mln Capital IQ Consensus Estimate. Non-GAAP operating margin is expected to be approximately 1% (was approximately zero per guidance provided on May 29, 2014).
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM